Line 1,812: |
Line 1,812: |
| |NEW (No Prior) | | |NEW (No Prior) |
| |- | | |- |
− | |[[HAEM5:EBV-positive diffuse large B-cell lymphoma|EBV-positive diffuse large B-cell lymphoma]]||Disease||Fnu Monika (trainee) + Andrew Siref as mentor | + | |[[HAEM5:EBV-positive diffuse large B-cell lymphoma|EBV-positive diffuse large B-cell lymphoma]]||Disease||Fnu Monika (trainee) + Andrew Siref as mentor |
| |3/22/24|| ||Pending|| ||GC|| || | | |3/22/24|| ||Pending|| ||GC|| || |
| |NEW (No Prior) | | |NEW (No Prior) |
Line 2,141: |
Line 2,141: |
| |NEW (No Prior) | | |NEW (No Prior) |
| |- | | |- |
− | |[[HAEM5:Autoimmune lymphoproliferative syndrome|Autoimmune lymphoproliferative syndrome]]||Disease|| || || || || ||SK|| || | + | |[[HAEM5:Autoimmune lymphoproliferative syndrome|Autoimmune lymphoproliferative syndrome]]||Disease||Aviv Oren, MD (trainee), mentor needed |
| + | | || || || ||SK|| || |
| |NEW (No Prior) | | |NEW (No Prior) |
| |NEW (No Prior) | | |NEW (No Prior) |
Line 2,326: |
Line 2,327: |
| |NEW (No Prior) | | |NEW (No Prior) |
| |- | | |- |
− | |[[HAEM5:Enteropathy-associated T-cell lymphoma|Enteropathy-associated T-cell lymphoma]]||Disease||Monika Fnu (trainee), Andrew Siref, MD | + | |[[HAEM5:Enteropathy-associated T-cell lymphoma|Enteropathy-associated T-cell lymphoma]]||Disease||Fnu Monika, MBBS (trainee), |
| + | Andrew Siref, MD |
| |3/20/24 | | |3/20/24 |
| | ||Pending|| ||SK|| || | | | ||Pending|| ||SK|| || |
Line 2,335: |
Line 2,337: |
| | | | | |
| |- | | |- |
− | |[[HAEM5:Monomorphic epitheliotropic intestinal T-cell lymphoma|Monomorphic epitheliotropic intestinal T-cell lymphoma]]||Disease||Monika Fnu (trainee), Andrew Siref, MD | + | |[[HAEM5:Monomorphic epitheliotropic intestinal T-cell lymphoma|Monomorphic epitheliotropic intestinal T-cell lymphoma]]||Disease||Fnu Monika, MBBS (trainee), Andrew Siref, MD |
| |3/20/24 | | |3/20/24 |
| | ||Pending|| ||SK|| || | | | ||Pending|| ||SK|| || |
Line 2,427: |
Line 2,429: |
| |NEW (No Prior) | | |NEW (No Prior) |
| |- | | |- |
− | |[[HAEM5:EBV-positive nodal T- and NK-cell lymphoma|EBV-positive nodal T- and NK-cell lymphoma]]||Disease||Monika Fnu (trainee), Andrew Siref, MD||3/22/24|| ||Pending|| ||SK|| || | + | |[[HAEM5:EBV-positive nodal T- and NK-cell lymphoma|EBV-positive nodal T- and NK-cell lymphoma]]||Disease||Fnu Monika, MBBS (trainee), Andrew Siref, MD||3/22/24|| ||Pending|| ||SK|| || |
| |NEW (No Prior) | | |NEW (No Prior) |
| |NEW (No Prior) | | |NEW (No Prior) |